Groundbreaking Lymphatic Interventions and Drug Exploration
ID: 355758Type: Posted
Overview

Buyer

Advanced Research Projects Agency for Health (HHS-ARPAH)

Award Range

$1 - $50M

Eligible Applicants

Small Businesses

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Other

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355758

Additional Information

https://sam.gov/opp/29ef33c275b24adcaec1384e2643f7cd/view
Timeline
    Description

    The Advanced Research Projects Agency for Health (ARPA-H) is offering a federal grant opportunity titled "Groundbreaking Lymphatic Interventions and Drug Exploration" (GLIDE) aimed at fostering innovative solutions in lymphatic health. This initiative seeks to engage small businesses in developing groundbreaking interventions and drug exploration strategies, with a focus on enhancing health outcomes related to the lymphatic system. The program is critical for advancing research and development in science and technology, with funding available ranging from $1 to $50 million. Interested applicants should note that the proposal submission deadline is October 31, 2024, and can reach out to the GLIDE Team at GLIDE@arpa-h.gov for further inquiries. Additional details can be found on the SAM.gov posting.

    Point(s) of Contact
    GLIDE@arpa-h.gov
    Files
    No associated files provided.
    Similar Opportunities
    Health Science Futures: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Health Science Futures: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health" federal grant. This opportunity aims to support groundbreaking research projects that develop innovative technologies, tools, and platforms to address significant healthcare challenges and improve health outcomes across a wide range of diseases. Eligible applicants, specifically small businesses, are encouraged to submit solution summaries and proposals that align with the ARPA-H mission, focusing on transformative technologies, tools, and adaptable systems that can lead to revolutionary advances in medicine and healthcare. The grant does not require cost-sharing or matching, with an expected 100 awards available, and proposals are due by March 14, 2025. For further inquiries, interested parties can contact Mark Baxter at mark.baxter@arpa-h.gov or by phone at 301-827-4852.
    Resilient Systems Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting small businesses to submit proposals for innovative solutions aimed at addressing systemic challenges in healthcare through its Resilient Systems Office initiative. The agency seeks projects that enhance the adaptability, reliability, and interoperability of health systems, focusing on areas such as sociotechnical system innovation, health ecosystem integration, and adaptive solutions to improve health outcomes and reduce fragility in the healthcare landscape. This opportunity is critical for fostering advancements in health technologies and methodologies, with an expected 100 awards available. Proposals are due by March 14, 2025, and interested parties can contact Mark Baxter at mark.baxter@arpa-h.gov for further information.
    Proactive Health Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Proactive Health Office: Office-Wide Innovative Solutions Opening," aimed at advancing research projects that enhance health outcomes and healthspan for Americans. The initiative seeks innovative solutions focused on disease prevention, early detection methods, and system-level innovations to promote proactive health behaviors and interventions. This opportunity is particularly significant as it addresses the need for a shift from reactive medical treatments to proactive health strategies, emphasizing the importance of improving overall public health. Proposals are due by March 14, 2025, and interested applicants, specifically small businesses, can reach out to Mark Baxter at mark.baxter@arpa-h.gov for further information. Additional details can be found at the provided link.
    Scalable Solutions Office: Office-Wide Innovative Solutions Opening for Advanced Research Projects Agency for Health
    Active
    Advanced Research Projects Agency for Health
    The Advanced Research Projects Agency for Health (ARPA-H) is inviting proposals for the "Scalable Solutions Office: Office-Wide Innovative Solutions," aimed at enhancing healthcare access and affordability through innovative research and development projects. Proposals should focus on scalable technologies and interventions, collaborative distribution networks, and biomanufacturing innovations that address healthcare disparities, particularly in underserved communities. This initiative is critical for developing solutions that can be rapidly deployed and adapted to various contexts, ultimately improving health outcomes across diverse populations. Interested small businesses must submit their proposals by March 14, 2025, and can contact Mark Baxter at mark.baxter@arpa-h.gov for further information.
    DoD Arthritis, Focused Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the DoD Arthritis Focused Research Award (Funding Opportunity Number: HT942524ATRPFRA) to support innovative research aimed at improving patient care for individuals affected by arthritis. This grant encourages applications that explore high-risk, high-reward research addressing various types of arthritis, including osteoarthritis and rheumatoid arthritis, with a particular focus on the implications for military personnel and their families. The total funding available for FY24 is approximately $2.5 million, with individual project budgets capped at $750,000 for Research Level 2 and $500,000 for Research Level 1. Interested applicants must submit a pre-application by October 16, 2024, and a full application by October 30, 2024, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Multiple Sclerosis, Exploration - Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is inviting applications for the FY24 Multiple Sclerosis Exploration - Hypothesis Development Award (MSRP EHDA), aimed at fostering innovative research in the field of multiple sclerosis (MS). This grant program supports high-risk, high-gain research concepts that challenge existing paradigms and lay the groundwork for future scientific investigations, with a focus on areas such as central nervous system repair and mechanisms contributing to MS etiology. The total estimated funding for this program is approximately $2 million, with an expected eight awards, and applications must follow a two-step submission process, including a pre-application due by June 10, 2024, and a full application due by October 7, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Arthritis Research, Clinical Research Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Research Clinical Research Award (ATRP CRA) to support clinical research aimed at improving the understanding and management of various forms of arthritis, particularly in military personnel and their families. This grant program encourages innovative research proposals that address disease-specific factors and interventions, with a focus on enhancing patient outcomes and informing clinical care or policy. With an estimated total funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial, with applications due by October 30, 2024, and a pre-application deadline of October 16, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    Advanced Rehabilitation Research Training (ARRT) Program - Health and Function
    Active
    Administration for Community Living
    The Administration for Community Living is forecasting a grant opportunity under the Advanced Rehabilitation Research Training (ARRT) Program focused on health and function. This program aims to provide advanced research training to individuals with doctoral or similar advanced degrees, particularly in areas that enhance the effectiveness of services authorized under the Rehabilitation Act, with an emphasis on disability and rehabilitation research. The grant will support one project over a 60-month period, with funding ranging from $245,000 to $250,000, and is open to private and public institutions of higher education, excluding foreign entities. Interested applicants can reach out to Angel Miles at angel.miles@acl.hhs.gov or call 202-795-7304 for more information, with proposals due by December 3, 2024, and an estimated award date of June 1, 2025.
    CDMRP Neurofibromatosis Exploration-Hypothesis Development Award
    Active
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY24 Neurofibromatosis Exploration-Hypothesis Development Award, aimed at funding innovative research related to neurofibromatosis (NF). This grant supports the exploration of high-risk, high-gain concepts to enhance understanding and treatment of NF1, NF2, and schwannomatosis, with an estimated total program funding of $1.12 million and the expectation to fund approximately seven projects. The application process is two-tiered, requiring pre-applications by September 12, 2024, and full applications by October 3, 2024, with a focus on innovation, research feasibility, and impact on NF research and patient care. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management," aimed at addressing the national opioid public health crisis. This initiative encourages small businesses to develop innovative, non-addictive therapies and technologies for improved pain management, including new medications, pain-assessment devices, and treatment strategies for chronic pain. The funding available includes up to $275,766 for Phase I and $1,838,436 for Phase II grants, with applications due by April 4, 2025. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.